Daiwa Securities Group Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 141 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72
-21.7%
2,2630.0%0.00%0.0%
Q2 2023$92
+12.2%
2,263
+2.9%
0.00%0.0%
Q1 2023$82
+28.1%
2,199
+20.2%
0.00%
Q4 2022$64
-99.9%
1,829
+5.9%
0.00%
-100.0%
Q3 2022$97,000
-14.2%
1,727
-20.6%
0.00%0.0%
Q2 2022$113,000
+606.2%
2,174
+901.8%
0.00%
Q1 2022$16,000
-38.5%
2170.0%0.00%
Q4 2021$26,000
-23.5%
217
-13.9%
0.00%
Q3 2021$34,000
+54.5%
252
+88.1%
0.00%
Q2 2021$22,000
+100.0%
1340.0%0.00%
Q1 2021$11,000
+83.3%
134
+20.7%
0.00%
Q4 2020$6,0000.0%111
-61.5%
0.00%
Q3 2020$6,000
+50.0%
2880.0%0.00%
Q2 2020$4,0000.0%2880.0%0.00%
Q1 2020$4,0000.0%2880.0%0.00%
Q4 2019$4,0000.0%2880.0%0.00%
Q3 2019$4,000
-20.0%
2880.0%0.00%
Q2 2019$5,000
+25.0%
288
+23.1%
0.00%
Q1 2019$4,000
+33.3%
2340.0%0.00%
Q4 2018$3,000
-57.1%
2340.0%0.00%
Q3 2018$7,000
+16.7%
2340.0%0.00%
Q2 2018$6,000
+20.0%
2340.0%0.00%
Q1 2018$5,0002340.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders